Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls. - Wikidata - awgldk - TriplyDB

Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls.

Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls.

http://www.wikidata.org/entity/Q37837495

about

Synthetic DNA vaccine strategies against persistent viral infections Deletion of parasite immune modulatory sequences combined with immune activating signals enhances vaccine mediated protection against filarial nematodes CD8(+) T cells from mice transnuclear for a TCR that recognizes a single H-2K(b)-restricted MHV68 epitope derived from gB-ORF8 help control infection.Hiding lipid presentation: viral interference with CD1d-restricted invariant natural killer T (iNKT) cell activation Self-boosting vaccines and their implications for herd immunity Immune regulation and evasion of Mammalian host cell immunity during viral infection.Opportunistic intruders: how viruses orchestrate ER functions to infect cells.Evaluation of viral interference with MHC class I-restricted antigen processing and presentation using a flow cytometry-based approach.TAP mediates import of Mycobacterium tuberculosis-derived peptides into phagosomes and facilitates loading onto HLA-I.Viral miRNAs Alter Host Cell miRNA Profiles and Modulate Innate Immune Responses.Mechanism of activation of the BNLF2a immune evasion gene of Epstein-Barr virus by Zta.

P2860

Q27016078-9DEB8702-C2D7-4BE8-AE4F-5CFEBAF9FA8C Q28484629-C92C7C39-9BFE-4F05-B63F-26E897A39149 Q36120915-B0F8263D-8521-4776-B9EF-9769C36EE3A2 Q36395876-9B5ED38C-E9C4-4A98-A895-AC1D38BDBD17 Q36471228-75BBFFEE-D564-4F9F-89B9-6527C927149D Q36832077-262120BA-7BFB-4405-B30B-CC0684E78FC4 Q37610842-F9595EEE-2FE0-4A32-8387-EFCC6EA25DC3 Q39208715-CAAE4C70-64D8-4359-86E4-E601203E396C Q42254930-7A699E19-6B8B-4E1D-81FE-43586141EADB Q51737478-53C154C4-F3A1-49E7-8AB1-3EC44C07C919 Q54248129-5DAD0BF0-0112-4E68-95B6-D7B3974A7DAC

P2860

Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls.

http://www.wikidata.org/entity/Q37837495

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 February 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls.

@en

Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls.

@nl

type

label

Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls.

@en

Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls.

@nl

prefLabel

Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls.

@en

Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls.

@nl

P1433

Q37837495-485A4A87-A643-417B-93D2-FE72C0C278BE

P1476

Q37837495-119F7F64-EF13-4F81-B624-6AC2D1779B5C

P2093

Q37837495-0252BEBE-37F0-4177-8C4D-49B3C4C2D1D7

Q37837495-9BC4382C-AD33-42BA-9F7E-9A7F6A886BA4

Q37837495-C5145141-53E4-4814-A755-2BF88DCCE184

P2860

Q37837495-03ED7D24-2F0D-450D-8955-BCC4B364CD82

Q37837495-066B299A-4A50-465E-8C25-072B45B8F75C

Q37837495-0838D4FE-84DC-4856-80E4-33E3FF295BC2

Q37837495-0BA7E8B3-200B-4CA6-A196-4E024A16C09C

Q37837495-0D975DDF-642A-4B4E-8D19-0E0B979449F1

Q37837495-109671A7-0E4B-4A95-AABC-BF97BA2C6BC1

Q37837495-118E7B97-6103-4FC3-878D-8FAF4E52C381

Q37837495-1FEB0CBF-7923-48DD-9031-D93BF42F7605

Q37837495-2035CE81-F290-44F3-BDC2-E6FA54BB2B3C

Q37837495-20750FAF-5994-4EBD-BEBB-700237516A01

P2888

Q37837495-940D5135-83D4-41DA-A7BC-08C7D3A06925

P304

Q37837495-1EBCC0A4-AEF6-4889-AD07-26A7BDF211F6

P31

Q37837495-D2D600E1-96FC-4564-80F0-C22A6EED41E9

P356

Q37837495-EF7DD7CC-D998-4D48-93FC-949E25ACDB9D

P433

Q37837495-5D53BAB3-6DBD-4EED-A152-AB7B66047AE9

P478

Q37837495-6CE486BF-AEBA-4AE2-8A66-051D8F69D55C

P577

Q37837495-DCCF8ED9-82E2-4C5A-8F8B-9D1094777C7F

P6179

Q37837495-78A86C9E-000D-4AAE-8E70-F2AF95F0FF21

P698

Q37837495-C22EE227-E6B5-4140-8D28-331E12B37A4F

P356

P1433

Immunology & Cell Biology

P1476

Exploiting human herpesvirus immune evasion for therapeutic gain: potential and pitfalls.

@en

P2093

Daniëlle Horst

http://www.w3.org/2001/XMLSchema#string

Emmanuel J H J Wiertz

http://www.w3.org/2001/XMLSchema#string

Maaike E Ressing

http://www.w3.org/2001/XMLSchema#string

P2860

Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing

Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction

The order Herpesvirales

Gamma-herpesvirus latency requires T cell evasion during episome maintenance

Insights into MHC Class I Peptide Loading from the Structure of the Tapasin-ERp57 Thiol Oxidoreductase Heterodimer

Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing

The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP

Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP

The human cytomegalovirus gene product US6 inhibits ATP binding by TAP

Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells.

P2888

P304

359-366

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/ICB.2010.129

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1037871664

http://www.w3.org/2001/XMLSchema#string

P698

21301483

http://www.w3.org/2001/XMLSchema#string